First Patient Dosed in 203Pb-RMX-VH-PIB Study for Cancer
11 Sep 2025 //
GLOBENEWSWIRE
Jérôme Berger announced as strategy & executive at Vect-Horus
28 Jan 2025 //
PHARMAFILE
Vect-Horus Appoints Dr Jean-Manuel Péan as Chief Scientific Officer
03 Apr 2023 //
BUSINESSWIRE
Vect-Horus Strengthens its Scientific Advisory Board; Appoints Frédéric Matonti
10 May 2022 //
BUSINESSWIRE
Vect-Horus Strengthens Scientific Advisory Board; Appoints Dr. Julia Alterman
22 Mar 2022 //
BUSINESSWIRE
Illumina Wins Patent Infringement Suit against BGI in the UK
20 Jan 2021 //
BUSINESSWIRE
VECT-HORUS and CERIMED Announce Collaboration to Support the Development
17 Nov 2020 //
BUSINESSWIRE
Vect-Horus and RadioMedix Announce Signing of a Letter of Intent
05 Mar 2019 //
BUSINESSWIRE